Fmoc-L-Thr(tBu)-MPPA

Nombre químico: N-alpha-(9-Fluorenylmethyloxycarbonyl)-O-t-butyl-L-threonine-3-(4-oxymethylphenoxy)propionic acid // Sinónimos: 3-(4-(((N-(((9H-fluoren-9-yl)methoxy)carbonyl)-O-(tert-butyl)-L-threonyl)oxy)methyl)phenoxy)propanoic acid, O-(1,1-Dimethylethyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-threonine[4-(2-carboxyethoxy) phenyl]methyl ester, Fmoc-Thr(tBu)-MPPA

  • Nº Artículo:LW01702
  • Nº CAS:864876-97-1
  • Fórmula:C33H37NO8
  • Storage temperature:2-8°C
  • Masa molecular:575,66 g/mol

from 95,00 €

Grouped product items
Cantidad Unidad de venta Precio Unidad de almacenamiento de stock (SKU) Disponibilidad
1 g
95,00 €
LW01702.0001
<10 días laborables
5 g
375,00 €
LW01702.0005
<10 días laborables
description

This Fmoc-amino acid-MPPA linker serves as precursor for the linkage to e.g. aminomethyl supports by standard coupling procedures. By this method, a low (max 0.5%) and reproducible epimerization level of the C-terminal amino acid in your peptide is guaranteed.


references

Improved approach for anchoring Nalpha-9-fluorenylmethyloxycarbonylamino acids as p-alkoxybenzyl esters in solid-phase peptide synthesis; F. Albericio, G. Barany; Int. J. Peptide. Protein. Res. 1985; 26(1): 92-97. https://doi.org/10.1111/j.1399-3011.1985.tb03182.x.


Amino acid derivatives used as agents bonding to a solid support; NeoMPS S.A. 2005; French Patent Application FR 0402973, International Patent Application WO2005/095332.


Structure-activity relationship study of the tumour-targeting peptide A20FMDV2 via modification of Lys16, Leu13, and N- and/or C-terminal functionality; K.-Y. Hung, P. W. R. Harris, A. Desai, J. F. Marshall, M. A. Brimble; Eur. J. Med. Chem. 2017; 136: 154-164. https://doi.org/10.1016/j.ejmech.2017.05.008.


¿Necesita más información sobre este producto?

ponerse en contacto

Contacto rápido

Por favor envíeme más información sobre

¡Otros productos que también podrían interesarle!